BERMAN DENNIS N 4
4 · Inhibikase Therapeutics, Inc. · Filed Feb 19, 2025
Insider Transaction Report
Form 4
BERMAN DENNIS N
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-02-14+39,620→ 39,620 totalExercise: $2.35Exp: 2035-02-14→ Common Stock (39,620 underlying)
Footnotes (1)
- [F1]The options vested and became exercisable on February 14, 2025.